Yuan-Deng Luo

Cancer type classification using plasma cell-free RNAs derived from human and microbes

Zhenjiang Zech Xu, Zhihua Liu, Hongyan Chen, 2021, eLife.

p53 haploinsufficiency and increased mTOR signaling define a subset of aggressive hepatocellular carcinoma.

P. Bie, Leida Zhang, Chuan-Ming Xie, 2020, Journal of hepatology.

Mutant Kras and mTOR crosstalk drives hepatocellular carcinoma development via PEG3/STAT3/BEX2 signaling

Chuan-Ming Xie, Lei Fang, Hongfu Yu, 2022, Theranostics.

PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells

P. Bie, Zhiyu Chen, Xingxing Su, 2019, Cell Death & Disease.

FBXW10 promotes hepatocarcinogenesis in male patients and mice.

F. Xia, P. Bie, Leida Zhang, 2020, Carcinogenesis.

ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis

P. Bie, Yi Gong, Wei Liu, 2019, Journal of experimental & clinical cancer research : CR.

Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1.

P. Bie, Zhiyu Chen, Yan Jiang, 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis

P. Bie, Yi Gong, Wei Liu, 2019, Journal of Experimental & Clinical Cancer Research.

Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma

P. Bie, Geng Chen, Leida Zhang, 2020, Cancer medicine.

Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice

Chuan-Ming Xie, Lei Fang, Hongfu Yu, 2023, Experimental & molecular medicine.